Saturday 17 October 2026
Export SOLS’s income statement to Excel — free account
Solstice Advanced Materials Inc.
SOLS Basic Materials Specialty Chemicals
Solstice Advanced Materials Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 3.08% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS fell 15.0%, free cash flow grew 70.8% and total debt rose 5,486.5%, each against the same quarter a year earlier.
59.25
0.67
−1.12%
Follow SOLS
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
P/E ratio |
33.17 | 33.17 | 33.17 |
P/S ratio |
2.02 | 2.02 | 1.98 |
Altman Z-Score |
— | — | 2.27 |
P/FCF ratio |
31.48 | 31.48 | 54.29 |
Altman Z″-Score (non-manufacturers) |
— | — | 1.87 |
Beneish M-Score |
— | — | (3.19) |
P/Operating CF |
(365.77) | (365.77) | 46.44 |
P/B ratio |
2.41 | 2.41 | 5.60 |
Price to Tangible BV |
3.31 | 3.31 | 15.18 |
EV/Sales |
1.94 | 1.94 | 2.38 |
EV/EBITDA |
8.31 | 8.31 | 11.08 |
EV/Operating CF |
13.07 | 13.07 | 20.33 |
EV/FCF |
30.21 | 30.21 | 65.15 |
Quick Ratio |
— | 1.14 | 0.69 |
Current Ratio |
— | 1.72 | 1.39 |
Net Debt/EBITDA |
0.00 | (0.61) | 1.85 |
Debt/Assets |
0.00% | 0.74% | 36.59% |
Debt/Equity |
0.00 | 0.01 | 1.51 |
Asset Turnover |
0.00 | 1.51 | 0.73 |
Operating CF/Net income |
1.22 | 1.42 | 1.92 |
Capex/Depreciation |
(1.30) | (1.36) | (1.50) |
Interest Coverage |
51.44 | 61.92 | 21.96 |
| 0.00% | 0.00% | 10.40% | |
| 0.00% | 23.74% | 4.44% | |
ROIC |
0.00% | 19.67% | 13.17% |
Return on Tangible Assets |
0.00% | 23.53% | 8.68% |
Average Days of Receivables |
0.00 | 55.09 | 60.58 |
Research and Development Expense of Revenue |
2.22% | 2.20% | 2.50% |
Selling, General and Administrative Expense of Revenue |
10.36% | 10.40% | 10.83% |
Intangible Assets out of Total Assets |
0.00 | 0.17 | 0.15 |
Share Based Compensation of Revenue |
0.49% | 0.45% | 0.69% |
Graham Net Nets |
(0.02) | (0.02) | (0.25) |
Graham Number |
0.00 | 0.00 | 0.00 |
Earnings Yield |
3.01% | 3.01% | 3.01% |
Free Cash Flow Yield |
3.18% | 3.18% | 1.84% |
Revenue per Share |
22.99 | 23.76 | 24.49 |
Operating CF per Share |
4.79 | 5.31 | 2.87 |
Capex per Share |
(1.81) | (1.87) | (2.07) |
Free Cash Flow per Share |
2.97 | 3.44 | 0.79 |
Cash per Share |
0.00 | 4.17 | 3.36 |
Shareholders Equity per Share |
0.00 | 20.05 | 8.68 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 20.05 | 8.68 |
Free Cash Flow |
472.00 | 546.00 | 126.00 |
Working Capital |
— | 778.00 | 675.00 |
Capital Expenditures |
(288.00) | (296.00) | (329.00) |
Net Current Asset Value |
0.00 | 39.00 | (1,908.00) |
EV/EBIT |
10.22 | 10.22 | 15.04 |
Capex to Sales |
0.08 | 0.08 | 0.08 |
Price to Operating Income |
10.65 | 10.65 | 12.54 |
| Other line items | |||
Depreciation/Fixed assets |
0.00 | 0.12 | 0.11 |
Cash ROIC |
0.00% | 14.07% | 3.16% |
Accounts Receivable Turnover |
0.00 | 0.00 | 6.40 |
Accounts Payable Turnover |
0.00 | 0.00 | 3.13 |
Inventory Turnover |
0.00 | 0.00 | 4.14 |
Average Days of Payables |
0.00 | 115.25 | 125.87 |
Days of Inventory on Hand |
0.00 | 82.66 | 99.00 |
Average Receivables |
— | — | 607.00 |
Average Payables |
— | — | 843.50 |
Average Inventory |
— | — | 636.50 |
Average Assets |
— | 2,502.00 | 5,338.50 |
Average Common Equity |
— | — | 2,279.50 |
Columns are period end dates